Drawing for EXELTIS RETHINKING HEALTHCARE

USPTO serial 79142730

EXELTIS RETHINKING HEALTHCARE

Reviewed by CopyMark Law Group

Reg. 4792387Status 739Registered
Filing date
Status date
Registration date
Aug 18, 2015
Examiner
SINGH, TEJBIR
Law office
Historical data usage

What this means

This trademark is registered with the USPTO. Monitoring new filings can help you catch lookalike marks early.

Need help with EXELTIS RETHINKING HEALTHCARE?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Arturo Perez-Guerrero

Arturo Perez-Guerrero Perez-Guerrero LLCP.O. Box 9024163San Juan, PR 00902-4163United States

Goods and services

ClassDescriptionStatusFirst use
005Pharmaceutical preparations for [ use in ] the treatment of [ ophthalmic diseases and disorders, dermatological diseases and disorders, digestive diseases and disorders, ] gynecological diseases and disorders; [ reagents for use in pregnancy tests; ] medical diagnostic reagents for use in ovulation tests; [ medical diagnostic reagents for use in testing for diabetes; ] contraceptives; pharmaceutical preparations for use in the treatment of hormonal diseases and disorders [ , blood disorders, cancer, cardiovascular diseases, vascular diseases, gastro-intestinal diseases, genitourinary diseases, * gastrointestinal disease, genitourinary disorders, * immunological diseases, infectious diseases, inflammatory diseases, metabolic diseases and disorders; pharmaceutical preparations for use in the treatment of neurological diseases and disorders, psychiatric diseases, diseases of the central nervous system, diseases of the musculoskeletal system, diseases of the respiratory system, diseases of the circulatory system, * circulatory diseases, * viral diseases, glaucoma, dental and mouth diseases, headaches, migraines, obesity, cholesterol, in liver treatment * treatment of the liver * ] ; nutraceutical preparations for use as a dietary supplement; pharmaceutical [ preparations ] * products * for treating [ blood pressure and rheumatism; veterinary preparations for the treatment of digestive diseases and disorders, ] gynecological diseases and disorders [ , blood disorders, cancer, the treatment of cardiovascular diseases, vascular diseases, gastrointestinal diseases, genitourinary diseases, immunological diseases, * disorders, * infectious diseases, inflammatory diseases, metabolic diseases and disorders, the treatment of neurological diseases, the treatment of viral diseases, glaucoma, dental and oral diseases, headaches, migraines, obesity, liver treatment * treatment of the *, cholesterol; nutraceutical veterinary preparations for use as a dietary supplement; veterinary preparations for the treatment of blood pressure and for rheumatism; and dietetic foods, namely, crackers adapted for medical use * ; none of the aforesaid products are preparations in connection with neuroscience, including dementia, Alzheimer's disease and Parkinson's disease * ]ACTIVE—
010[ Surgical apparatus and instruments, medical instruments for treating gynecological disorders, [ ophthalmological ] * ophthalmic * disorders, dermatological disorders, and respiratory and metabolic disorders; Medical test kits for diabetes monitoring for home use; orthopedic devices for diagnostic and therapeutic [ use ] * purposes * ; suture materials ]SECTION 71 - CANCELLED—
035[ Sales promotion for third parties, business management assistance; [ consulting ] * consultancy * on business management and marketing studies; ] presentation of goods on [ any kind of ] * all * communication media for retail sale [ ; commercial administration of licenses for the goods and services of others; organization of exhibitions, [ trade fairs or congresses for business ] * trade fairs and conventions for commercial * or advertising purposes, all relating to pharmaceutical, veterinary and biotechnological companies and for pharmaceutical, veterinary and biotechnological products * ; but none of the aforesaid goods relating to neuroscience, including dementia, Alzheimer's disease and Parkinson's disease or to goods in the field of neuroscience, including dementia, Alzheimer's disease and Parkinson's disease * ]ACTIVE—
042[ Chemical, biological and pharmaceutical research services * ; [ all ] * none of * the aforesaid goods relating to the field of neuroscience, including dementia, Alzheimer's disease and Parkinson's disease * ]SECTION 71 - CANCELLED—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Nov 12, 2026NREPNEW REPRESENTATIVE AT IB RECEIVED—
Jan 21, 2026NA75NOTICE OF ACCEPTANCE OF SEC. 71 & 15 - E-MAILED—
Jan 21, 2026C75AREGISTERED - SEC. 71 ACCEPTED & SEC. 15 ACK.—
Dec 30, 2025APRECASE ASSIGNED TO POST REGISTRATION PARALEGAL—
Aug 18, 2025ES75TEAS SECTION 71 & 15 RECEIVED—
Jul 23, 2025TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED—
Jul 23, 2025ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Jul 23, 2025REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED—
Aug 18, 2024REM4COURTESY REMINDER - SEC. 71 (10-YR) E-MAILED—
Jul 14, 2023RNWLINTERNATIONAL REGISTRATION RENEWED—
May 16, 2023INNPPARTIAL INVALIDATION PROCESSED BY THE IB—
Apr 4, 2023INPSPARTIAL INVALIDATION OF REG EXT PROTECTION SENT TO IB—
Apr 4, 2023INPCINVALIDATION PROCESSED—
Feb 12, 2023INPRPARTIAL INVALIDATION OF REG EXT PROTECTION CREATED—
Jun 12, 2022NA71NOTICE OF ACCEPTANCE OF SEC. 71 - E-MAILED—
Jun 12, 202271.PREGISTERED - PARTIAL SEC 71 ACCEPTED—
Jun 6, 2022APRECASE ASSIGNED TO POST REGISTRATION PARALEGAL—
Aug 16, 2021ES71TEAS SECTION 71 RECEIVED—
Aug 18, 2020REM3COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED—
Nov 29, 2018INNAINVALIDATION REVIEWED - NO ACTION REQUIRED BY OFFICE—
Nov 12, 2018INPRPARTIAL INVALIDATION OF REG EXT PROTECTION CREATED—
Mar 13, 2018LIMELIMITATION FROM THE IB EXAMINED AND ENTERED—
Mar 12, 2018COC.CORRECTION UNDER SECTION 7 - PROCESSED—
Mar 12, 2018APRECASE ASSIGNED TO POST REGISTRATION PARALEGAL—
Nov 28, 2017LIMELIMITATION FROM THE IB EXAMINED AND ENTERED—
Oct 16, 2017CORRCORRECTION FROM IB ENTERED - NO REVIEW REQUIRED—
Oct 14, 2017COC.CORRECTION UNDER SECTION 7 - PROCESSED—
Oct 14, 2017APRECASE ASSIGNED TO POST REGISTRATION PARALEGAL—
Oct 6, 2017LIMGLIMITATION OF GOODS RECEIVED FROM IB—
Sep 22, 2017CRCVCORRECTION TRANSACTION RECEIVED FROM IB—
Sep 21, 2017LIMGLIMITATION OF GOODS RECEIVED FROM IB—
May 2, 2017INNAINVALIDATION REVIEWED - NO ACTION REQUIRED BY OFFICE—
Mar 1, 2017INPRPARTIAL INVALIDATION OF REG EXT PROTECTION CREATED—
Jul 6, 2016LIMELIMITATION FROM THE IB EXAMINED AND ENTERED—
Jul 1, 2016COC.CORRECTION UNDER SECTION 7 - PROCESSED—
Feb 20, 2016FINOFINAL DECISION TRANSACTION PROCESSED BY IB—
Feb 2, 2016FICSFINAL DISPOSITION NOTICE SENT TO IB—
Feb 2, 2016FIMPFINAL DISPOSITION PROCESSED—
Dec 18, 2015LIMGLIMITATION OF GOODS RECEIVED FROM IB—
Nov 18, 2015FICRFINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB—
Aug 19, 2015EXPTEXPARTE APPEAL TERMINATED—
Aug 18, 2015R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Aug 7, 2015OPNXNOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB—
Jul 22, 2015OPNSNOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB—
Jul 22, 2015OPNRNOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB—
Jun 2, 2015NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Jun 2, 2015PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Jun 1, 2015GPNXNOTIFICATION PROCESSED BY IB—
May 13, 2015OPNSNOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB—
May 13, 2015OP2RNOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB—
May 13, 2015NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Apr 27, 2015PREVLAW OFFICE PUBLICATION REVIEW COMPLETED—
Apr 27, 2015CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Apr 27, 2015XAECEXAMINER'S AMENDMENT ENTERED—
Apr 27, 2015GNENNOTIFICATION OF EXAMINERS AMENDMENT E-MAILED—
Apr 27, 2015GNEAEXAMINERS AMENDMENT E-MAILED—
Apr 27, 2015CNEAEXAMINERS AMENDMENT -WRITTEN—
Mar 12, 2015TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Mar 12, 2015CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Mar 9, 2015ALIEASSIGNED TO LIE—
Mar 3, 2015EXPIEX PARTE APPEAL-INSTITUTED—
Mar 3, 2015JURTJURISDICTION RESTORED TO EXAMINING ATTORNEY—
Mar 2, 2015ERFRTEAS REQUEST FOR RECONSIDERATION RECEIVED—
Mar 2, 2015EXAFEXPARTE APPEAL RECEIVED AT TTAB—
Aug 29, 2014GNFNNOTIFICATION OF FINAL REFUSAL EMAILED—
Aug 29, 2014GNFRFINAL REFUSAL E-MAILEDA final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon.
Aug 29, 2014CNFRFINAL REFUSAL WRITTENA final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon.
Aug 26, 2014TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Aug 25, 2014CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Aug 25, 2014TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Aug 25, 2014ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Aug 25, 2014REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED—
Mar 14, 2014RFNTREFUSAL PROCESSED BY IB—
Feb 28, 2014MAFRAPPLICATION FILING RECEIPT MAILED—
Feb 25, 2014RFCSNON-FINAL ACTION MAILED - REFUSAL SENT TO IB—
Feb 25, 2014RFRRREFUSAL PROCESSED BY MPU—
Feb 25, 2014RFCRNON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW—
Feb 24, 2014CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Feb 24, 2014DOCKASSIGNED TO EXAMINER—
Feb 24, 2014NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Feb 21, 2014REPRSN ASSIGNED FOR SECT 66A APPL FROM IB—

Frequently asked questions

Related guidance